science

Vertex to acquire Crinetics Pharmaceuticals in $10B deal

Basel, July 6, 2026 - Novartis today announced that it has entered into an agreement to acquire Myricx Bio (“Myricx”), a privately held UK-based biotechnology company developing a new class of antibody-drug conjugates (ADCs), using N-myristoyltransferase inhibitor (NMTi) payloads.

LONDON, July 06, 2026 (GLOBE NEWSWIRE) -- Myricx Bio, a UK-headquartered biotech company focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates (ADCs), today announced that it has reached agreement to be acquired by Novartis for up to $1.5 billion includi

Genesis delivers binding A$5.6B "superior proposal" to merge with Vault Minerals

PARIS & LONDON--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to $1.5 billion including $1.1 billion cash upfront plus potential mil

Australian gold miner Genesis Minerals Ltd. has launched a last-minute cash and stock bid for Vault Minerals Ltd. which had already agreed to a deal with Regis Resources Ltd.

After the “lean in” generation, are professional women leaning out?

SpaceX bandwagon gets two new engines this week

Why Did General Motors (GM) Just Partner With Micron?

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,